NCT03451071View on ClinicalTrials.gov

Postpartum HPV Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

December 30, 2020

Conditions
HPV-Related Malignancy
Interventions
DRUG

Gardasil9

Gardasil 9

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT03451071 - Postpartum HPV Vaccination | Biotech Hunter | Biotech Hunter